Advertisement

Topics

Oxford Nanoimaging Nanoimager for super-resolution, single-molecule imaging

20:00 EDT 6 Aug 2017 | Australian Life Scientist

The Nanoimager from Oxford Nanoimaging represents a revolution in single-molecule imaging, according to the company. Offering super-resolution capabilities in a compact, benchtop system, the Nanoimager is claimed to be a game changer for high-resolution imaging.

With a purpose-designed and fully optimised optical path, the imager allows operators of any level to capture sensitive single-molecule fluorescence images using an easy-to-use interface. With the ability to resolve features down to 20 nm, the Nanoimager is particularly advantageous to users.

The product is highly compact, with no daily alignment required. It operates on a laboratory bench and supports live-cell imaging. Imaging techniques available include widefield epifluorescence, TIRF, HILO, dSTORM, PALM, single-molecule FRET and single-molecule tracking.

The compact design belies the high performance built into the imager, with features including a motorised stage; FOV image stitching (sample overview); low drift and thermal stabilisation; Z-position (focus) automation; user-defined positions scanning; remote operation; programmable acquisitions; and powerful and intuitive acquisition/control software.

Original Article: Oxford Nanoimaging Nanoimager for super-resolution, single-molecule imaging

NEXT ARTICLE

More From BioPortfolio on "Oxford Nanoimaging Nanoimager for super-resolution, single-molecule imaging"

Quick Search
Advertisement
 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...